Advertisement Integrity, Cornerstone merge to form new company - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Integrity, Cornerstone merge to form new company

US-based Integrity Nutraceuticals has merged with Cornerstone Research and Development, a developer and manufacturer of nutritional supplements and OTC products.

The merger, in combination with an expansive capital investment program, will create product development and production capabilities across 600,000ft² of manufacturing space.

The combined scale and breadth of services spanning both the Tennessee and Utah facilities will be unparalleled in the industry and will allow the combined company to provide a unique value proposition to customers.

Combined company’s CEO Peter Miller said Cornerstone’s impeccable reputation for pharmaceutical-grade quality, strong innovation and manufacturing expertise make it a perfect complement to its business.

"Additionally, having access to their extensive production capabilities across a variety of product formats and being able to offer our customers a bi-coastal manufacturing and distribution footprint is a significant competitive advantage," Miller said.

Combined company president Mike Beardall said they are happy to combine their resources with Integrity.

"This is great news for our customers and changes the game for nutritional supplement manufacturing," Beardall said.

"With expanded capacity, enhanced capabilities, and new product development resources, we will continue to build on Cornerstone’s strong heritage of providing best-in-class services to our customers."

Research, development, formulation and manufacturing services for the nutrition industry remain highly fragmented, with varying levels of quality, capability and service.